|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||6.79 - 7.14|
|52-week range||6.79 - 7.14|
|Beta (5Y monthly)||-0.32|
|PE ratio (TTM)||N/A|
|Earnings date||05 May 2021 - 10 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Shares of Homology Medicines (NASDAQ: FIXX) were sinking 17.8% lower as of 12:01 p.m. EDT on Wednesday. The decline came after the company announced the pricing of its latest public stock offering. Biotech stocks usually fall after public stock offerings are announced.
Homology Medicines (FIXX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Homology Medicines (FIXX) delivered earnings and revenue surprises of 4.62% and 130.59%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?